Drug interactions can result from interference between the pharmacological action of the drug – for example through action on the same receptor or a similar biological process – or it may be due to interference with drug absorption, metabolism or clearance leading to altered drug levels at the site of action. It is important to bear in mind that drug interactions can also occur between non‐prescribed drugs such as over the counter medicines or herbal remedies. St John's Wart can be bought in health food shops and is known to interfere with the metabolism of many drugs. Grapefruit juice is also known to alter the bioavailability of many drugs.
Pharmacodynamic interactions
These tend to involve the administration of two drugs with similar effects. Such interactions may involve two agents acting at one receptor (attenuation of salbutamol's bronchodilatory effect by non‐specific beta‐blockers) or through a less specific effect upon particular tissues (potentiation of the sedative effect of benzodiazepines by alcohol). Pharmacodynamic interactions at one receptor may have therapeutic use, such as the reversal of opiate toxicity by naloxone. The clinical effects are largely predictable and can be prevented by thoughtful prescribing.
Pharmacokinetic interactions
These interactions involve interference with absorption, distribution or metabolism of one drug as a consequence of the administration of another. They tend to be less easy to predict than pharmacodynamic interactions, although the consequences may be no less severe. Some commonly encountered pharmacokinetic interactions are summarised in Table 4.2.
Table 4.2 Examples of pharmacokinetic interactions.
Absorption interactions |
Tetracyclines chelate calcium, iron and magnesium salts leading to reduced antibiotic absorption |
Cholestyramine reduces warfarin absorption by binding to it |
Distribution interactions |
Aspirin displaces warfarin from plasma proteins, potentiating the anti‐coagulant effect |
Meropenem displaces valproate from its protein binding sites leading to greatly increased clearance of valproate and rapid loss of effect |
Metabolism interactions |
Induction |
Carbamazepine induces enzymes which metabolise phenytoin, necessitating larger doses of phenytoin |
The antibiotic rifampicin is a potent inducer of many enzymes involved in drug metabolism and causes many troublesome pharmacokinetic drug interactions |
Inhibition |
Macrolide antibiotics such as clarithromycin inhibit metabolic enzymes in the liver leading to increased drug levels of many drugs including many statins such as simvastatin |
Allopurinol potentates the cytotoxic effect of azathioprine by inhibiting xanthine oxidase, the enzyme responsible for its enzymatic degradation |
An exhaustive list of all potential interactions lies out with the scope of this text. Appendix 1 of the BNF provides a useful reference, and should be consulted whenever the question of a potential interaction arises.
Clinical scenario
A 74‐year‐old man with high blood pressure is admitted to hospital for a routine operation (transurethral resection of prostate). The admitting doctor writes up his drug chart for the three different blood pressure tablets he is normally prescribed. The day after his operation he is given the three drugs by the nurse doing the drug round. The patient then complains of dizziness on standing and is noted to have a low blood pressure with postural drop. Is there a problem with adherence?
Adherence is the degree to which a patient takes the treatment(s) prescribed for them as directed. The old term for this is compliance, although compliance has fallen out of use since it implies that the patient is being told what to do by their prescriber and may have a paternalistic overtone.
Adherence is important in reproducing the expected clinical effect of a drug. Clearly if the patient takes a medication infrequently or not at all, then this is likely to mean that they derive less benefit and is a common reason why ‘real world’ benefits of drugs may be less than seen in clinical trials, in which adherence is usually higher.
Many factors influence adherence. Good explanation and understanding on the part of the patient of why they are being prescribed a drug and a perception that the drug will be helpful is important. Similarly important are a convenient method of administration and an absence of significant side effects. A side effect that a patient may tolerate when taking a week‐long course of antibiotics may not be tolerated if the same adverse effect occurs during long‐term prescribing for a chronic health condition such as hypertension. The effect of tablet burden and multiple prescribing is often underestimated. There is strong evidence that adherence is reduced even when prescribing two rather than one tablet and this effect is even greater if patients are taking larger numbers of tablets or multiple daily dosing. Clearly such problems cannot always be avoided, but the impact of being asked to take several tablets several times per day should not be underestimated.
A number of methods can be useful to promote good adherence. A good therapeutic relationship between patient and prescriber is helpful and explanations should be clear and appropriate. It is useful to routinely ask patients about their adherence and such questions should be asked in a non‐confrontational way that does not imply disapproval. Many patients fear telling medical professionals that they forget to take prescribed medications. Dedicated counselling can be useful, particularly if adherence is particularly difficult or appropriate. Drug administration aids such as tablet boxes or packaged doses can be very useful, particularly for patients with complex drug regimes. Many patients find that setting an alarm or reminder on a smartphone can be very helpful.
Usually prescribing should be thoughtful and prescribing in a hurry should generally be avoided. Occasionally, an emergency situation means that delay is not possible and so prescribers should be aware of the emergency drugs that they may be asked to prescribe and any complications that may arise. These are generally taught as part of immediate and advanced life support courses.
Part 2 Aspects of prescribing
Конец ознакомительного фрагмента.
Текст предоставлен ООО «ЛитРес».
Прочитайте эту книгу целиком, купив полную легальную версию на ЛитРес.
Безопасно оплатить книгу можно банковской картой Visa, MasterCard, Maestro, со счета мобильного телефона, с платежного терминала, в салоне МТС или Связной, через PayPal, WebMoney, Яндекс.Деньги, QIWI Кошелек, бонусными картами или другим удобным Вам способом.